STAT

One dead, four hospitalized after receiving OpenBiome stool transplants

Two people died and four were hospitalized after they received stool transplants from OpenBiome, the FDA and the commercial stool bank announced Thursday.
A technical assistant displays a bottle containing human fecal matter solution, frozen to minus 80 degrees celsius, in an OpenBiome laboratory, in Medford, Mass.

Update: This story and its headline were changed to reflect an update from the FDA, posted Friday, March 13 that included additional information about the two patients who died.

One person died and four were hospitalized after they received stool transplants from OpenBiome, the Food and Drug Administration and the commercial stool bank announced Thursday.

The FDA’s original safety alert said eight patients may have been affected by stool transplants from three donors whose stool contained illness-causing bacteria. For six patients who

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About The Purdue Bankruptcy Ruling, A Merck Rejection, And More
In today's Pharmalittle roundup, we're reading about the Purdue bankruptcy ruling, a Merck rejection, and more.
STAT1 min read
STAT+: How Controversial Was The Decision By FDA’s Peter Marks To Approve Sarepta’s Gene Therapy? Check Its Footnotes
The unilateral decision by Peter Marks, a top FDA official, to approve a gene therapy for Duchenne muscular dystrophy looks even more surprising on a close examination.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Lilly’s Alzheimer’s Drug, An EU Contract For Bird Flu Vaccine, And More
Advisers to the FDA voted unanimously to recommend the approval of a drug for early Alzheimer’s disease made by Eli Lilly.

Related Books & Audiobooks